HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Guideline-based care of common mental disorders by occupational physicians (CO-OP study): a randomized controlled trial.

AbstractOBJECTIVE: To evaluate the effectiveness of guideline-based care (GBC) of workers with mental health problems, which promotes counseling by the occupational physician (OP) facilitating return to work (RTW). METHODS: In a randomized controlled trial with police workers on sick leave due to mental health problems (n = 240), trained OPs delivered GBC in the intervention group. Time to RTW and recurrences during 1-year follow-up, analyzed using Cox proportional hazards models, were compared with usual care (UC) with easy access to a psychologist. RESULTS: GBC by OPs did not result in earlier RTW than UC. Subgroup analysis showed a small effect in favor of GBC for workers with administrative functions and/or "minor" stress-related symptoms. CONCLUSIONS: GBC did not differ in RTW compared with UC, but may be beneficial for the majority of workers with minor stress-related disorders.
AuthorsD S Rebergen, D J Bruinvels, P D Bezemer, A J van der Beek, W van Mechelen (Affiliation: Departments of Public and Occupational Health, EMGO Institute, VU University Medical Center, Amsterdam, The Netherlands.)
JournalJournal of occupational and environmental medicine / American College of Occupational and Environmental Medicine (J Occup Environ Med) Vol. 51 Issue 3 Pg. 305-12 (Mar 2009) ISSN: 1536-5948 [Electronic] United States
PMID19225417 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Female
  • Humans
  • Male
  • Mental Disorders (therapy)
  • Middle Aged
  • Netherlands
  • Occupational Health
  • Outcome Assessment (Health Care)
  • Police
  • Practice Guidelines as Topic
  • Proportional Hazards Models
  • Psychology
  • Sick Leave

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD